Fibromatosis: a potential sequela of neuromuscular choristoma
Clinical article
Search for other papers by Marie-Noëlle Hébert-Blouin in
Current site
Google Scholar
PubMed
Search for other papers by Bernd W. Scheithauer in
Current site
Google Scholar
PubMed
Radiology, and
Search for other papers by Kimberly K. Amrami in
Current site
Google Scholar
PubMed
Search for other papers by Susan R. Durham in
Current site
Google Scholar
PubMed
Orthopedics, Mayo Clinic, Rochester, Minnesota; and
Search for other papers by Robert J. Spinner in
Current site
Google Scholar
PubMed
Object
Neuromuscular choristoma (NMC) is a rare peripheral nerve lesion in which mature skeletal muscle fibers lie within the nerve and its fascicles. Given limited follow-up, its natural history is poorly understood. The occurrence of aggressive fibromatosis in one of the authors' patients and its occurrence in reported cases suggests an etiological relationship between the 2 lesions. This study attempts to explain the association and its frequency.
Methods
All cases of NMCs seen in consultation or treated at the Mayo Clinic were identified. Demographic and clinical data were reviewed in cases with coexistent aggressive fibromatosis. Pathology and neuroimaging studies were reexamined. In addition, an extensive literature review was performed to explore the association of NMC with aggressive fibromatosis, with special attention given to pathological and imaging characteristics and the development of aggressive fibromatosis.
Results
The authors identified 10 patients with a diagnosis of NMC who were treated at the Mayo Clinic between 1992 and 2010. Four of 5 with adequate follow-up had developed a definite or suspected aggressive fibromatosis. A review of the initial pathological specimens in these cases revealed no evidence of fibromatosis, but all of the lesions exhibited accompanying hypocellular collagenous tissue. On MR images, all cases showed areas of low signal intensity, which significantly differed from muscle, nerve, and NMC components. On available serial MR imaging studies, aggressive fibromatosis seemed to originate in such lower-intensity regions. In the 18 previously reported cases of NMC, 5 patients developed recurrent masses diagnosed as either definite (2 cases) or possible (3 cases) fibromatosis. Review of the published imaging studies in these cases suggests the presence of lower intensity areas similar to those observed in the 10 patients treated at the Mayo Clinic.
Conclusions
This study confirms that the development of aggressive fibromatosis in patients with NMC has been underreported. A direct relationship between the NMC and the development of aggressive fibromatosis is suggested by pathological and neuroimaging evidence.
Abbreviation used in this paper:
NMC = neuromuscular choristoma.
© Copyright 1944-2023 American Association of Neurological Surgeons